Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir (GENUPI)

Association HGE CHU Bordeaux Sud

Status: Completed

Conditions: Chronic Hepatitis C

Study type: Observational

Funder types: Other

Identifiers

NCT01577069

UDPS-100211

Details and patient eligibility

About

The purpose of the study is to

1- detect and quantify HCV-PI resistant mutants with ultra-deep pyrosequencing (UDPS) technology, 2 - detect SNPs in P-glyocoprotein and CYP3A genes, in HCV mono-infected patients under/after Telaprevir treatment.

Enrollment: 73 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HCV mono-infected subjects
• Age > 18 years

Exclusion criteria

• HBV co-infection